In short
Hims & Hers Health, Inc. (HIMS) has revenue up 59.0% to $2.3B and EPS (Diluted) down 3.8% to $0.51 year on year. Its net margin is 5.5% and gross margin 73.8%. Fisclear flags 1 medium-severity risk and no high-severity ones. How we calculate this
Valuation
HealthcareLive · Yahoo FinancePrice
$14.60
$3.4B
52-Week Range
Decision Context
Beneish M-Score flags possible earnings quality concerns. The financial metrics above warrant additional scrutiny of reported figures.
Based on filing period ending Sept 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
Fed Funds Rate
3.88%
Accommodative
10-Year Treasury
5.13%
2026-10-01
Unemployment
4.1%
Near full employment
CPI Index
336.3
2026-09-01
M2 Money Supply
$23.4T
2026-09-01
The Federal Funds rate stands at 3.88% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 5.13%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.1%; Industrial production index is at 104.0; M2 money supply is $23.4T; CPI index stands at 336.3.
SWOT Analysis — HIMS
Inflationary BoomStrengths
Total Assets: $2.2B (+204.5% YoY) — Total assets grew 205% — the company's resource base expanded.
Revenue: $2.3B (+59.0% YoY) — Revenue grew 59% — the company sold more goods or services than the prior year.
Gross Profit: $1.7B (+47.8% YoY) — Gross profit rose 48% — the spread between revenue and direct costs improved.
Operating Cash Flow: $300.0M (+19.5% YoY) — Operating cash flow grew 19% — the business generated more cash from day-to-day operations.
Weaknesses
EPS (Diluted): $0.51 (-3.8% YoY) — Earnings per share fell 4%.
Gross margin narrowed by 5.6pp — worth monitoring for further cost pressure.
Beta of 2.50x — this stock moves significantly more than the broader market, amplifying both gains and drawdowns.
Opportunities
No clear opportunities identified at this time.
Threats
Total liabilities represent 75% of total assets — elevated leverage that amplifies both gains and losses.
Year-over-Year Changes
Total Assets
$2.2B
was $707.5M
Total assets grew 205% — the company's resource base expanded.
Revenue
$2.3B
was $1.5B
Revenue grew 59% — the company sold more goods or services than the prior year.
Gross Profit
$1.7B
was $1.2B
Gross profit rose 48% — the spread between revenue and direct costs improved.
Operating Cash Flow
$300.0M
was $251.1M
Operating cash flow grew 19% — the business generated more cash from day-to-day operations.
EPS (Diluted)
$0.51
was $0.53
Earnings per share fell 4%.
Risk Flags
0 high · 1 medium · 2 low- ◈ Medium
Total liabilities represent 75% of total assets — elevated leverage that amplifies both gains and losses.
- ○ Low
Gross margin narrowed by 5.6pp — worth monitoring for further cost pressure.
- ○ Low
Beta of 2.50x — this stock moves significantly more than the broader market, amplifying both gains and drawdowns.
Technical Signals
Daily closes · 1-year dataHims & Hers Health, Inc.: common questions
Is Hims & Hers Health, Inc. profitable?
Yes. Hims & Hers Health, Inc. made a net profit of $128M in its latest fiscal year (fiscal 2025), a net margin of 5.5%.
Is Hims & Hers Health, Inc.'s revenue growing?
Yes. Revenue grew 59.0% year on year, to $2.3B.
Does Hims & Hers Health, Inc. pay a dividend?
No dividend is currently expected from Hims & Hers Health, Inc., according to the latest market data.
What are the main risks for Hims & Hers Health, Inc.?
Fisclear's checks flag 1 medium- or high-severity risk. The most serious: Total liabilities represent 75% of total assets — elevated leverage that amplifies both gains and losses.
Answers are generated from the figures in this report (updated 10 Nov 2026). Information, not investment advice.
Latest News
via FinnhubFiling History — HIMS
Get the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade HIMS
Links open broker research pages. Not an endorsement or recommendation.
Research Hims & Hers Health, Inc.
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.